Optimal treatment of laryngopharyngeal reflux disease

Therapeutic Advances in Chronic Disease

Volumn 4, Issue 6, 2013, Pages 287-301

  Bortoli, Nicola ^a   Martinucci, Irene ^b   Bellini, Massimo ^b   Marchi, Santino ^b   Savarino, Edoardo ^c   Nacci, Andrea ^b   Romeo, Salvatore Osvaldo ^b   Fattori, Bruno ^b   Savarino, Vincenzo ^d  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Gastroesophageal reflux disease; Laryngopharyngeal reflux; Proton pump inhibitor; Treatment

Indexed keywords

ADX 10059; ALGINIC ACID; ARBACLOFEN; BACLOFEN; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LESOGABERAN; METABOTROPIC RECEPTOR ANTAGONIST; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RABEPRAZOLE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ANTIREFLUX OPERATION; BODY MASS; BREATHING EXERCISE; CARBONATED BEVERAGE; COFFEE; DIETARY INTAKE; EATING HABIT; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LARYNGOPHARYNGEAL REFLUX; LIFESTYLE MODIFICATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP; SMOKING; SPEECH THERAPY; SYSTEMATIC REVIEW (TOPIC);

EID: 84890216218     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622313503485     Document Type: Article

References (143)

1. Altman K. Prufer N. Vaezi M. (2011) A review of clinical practice guidelines for reflux disease: toward creating a clinical protocol for the otolaryngologist. Laryngoscope 121: 717–723.
2. Anderson J. Jhaveri M. (2010) Reductions in medications with substantial weight loss with behavioral intervention. Curr Clin Pharmacol 5: 232–238.
3. Bardhan K. Strugala V. Dettmar P. (2012) Reflux revisited: advancing the role of pepsin. Int J Otolaryngol 2012: 646901.
4. Bough I. Jr Sataloff R. Castell D. Hills J. Gideon R. Spiegel J. (1995) Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice 9: 205–211.
5. Branski R. Bhattacharyya N. Shapiro J. (2002) The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 112: 1019–1024.
6. Brazer S. Onken J. Dalton C. Smith J. Schiffman S. (1995) Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physiol Behav 57: 563–567.
7. Broekaert D. Fischler B. Sifrim D. Janssens J. Tack J. (2006) Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 23: 365–370.
8. Carroll T. Fedore L. Aldahlawi M. (2012) pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope 122: 2473–2481.
9. Carvalho de Miranda Chaves R. Suesada M. Polisel F. de Sa C. Navarro-Rodriguez T. (2012) Respiratory physiotherapy can increase lower esophageal sphincter pressure in GERD patients. Respir Med 106: 1794–1799.
10. Catania R. Kavic S. Roth J. Lee T. Meyer T. Fantry G. et al. (2007) Laparoscopic Nissen fundoplication effectively relieves symptoms in patients with laryngopharyngeal reflux. J Gastrointest Surg 11: 1579–1587; discussion 1587–1578.
11. Chen R. Thomas R. (2000) Results of laparoscopic fundoplication where atypical symptoms coexist with oesophageal reflux. Aust N Z J Surg 70: 840–842.
12. Chevalier J. Brossard E. Monnier P. (2003) Globus sensation and gastroesophageal reflux. Eur Arch Otorhinolaryngol 260: 273–276.
13. Chiba N. de Gara C. Wilkinson J. Hunt R. (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112: 1798–1810.
14. Ciccaglione A. Marzio L. (2003) Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 52: 464–470.
15. Clouse R. Lustman P. Eckert T. Ferney D. Griffith L. (1987) Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 92: 1027–1036.
16. Collings K. Pierce Pratt F. Rodriguez-Stanley S. Bemben M. Miner P. (2003) Esophageal reflux in conditioned runners, cyclists, and weightlifters. Med Sci Sports Exerc 35: 730–735.
17. Cossentino M. Mann K. Armbruster S. Lake J. Maydonovitch C. Wong R. (2012) Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux - a randomised prospective study. Aliment Pharmacol Ther, in press.
18. Cranley J. Achkar E. Fleshler B. (1986) Abnormal lower esophageal sphincter pressure responses in patients with orange juice-induced heartburn. Am J Gastroenterol 81: 104–106.
19. de Bortoli N. Nacci A. Savarino E. Martinucci I. Bellini M. Fattori B. et al. (2012) How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol 18: 4363–4370.
20. de Groot N. Burgerhart J. van de Meeberg P. de Vries D. Smout A. Siersema P. (2009) Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther 30: 1091–1102.
21. Djarv T. Wikman A. Nordenstedt H. Johar A. Lagergren J. Lagergren P. (2012) Physical activity, obesity and gastroesophageal reflux disease in the general population. World J Gastroenterol 18: 3710–3714.
22. Dore M. Maragkoudakis E. Fraley K. Pedroni A. Tadeu V. Realdi G. et al. (2008) Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci 53: 2027–2032.
23. Eherer A. Habermann W. Hammer H. Kiesler K. Friedrich G. Krejs G. (2003) Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 38: 462–467.
24. Eherer A. Netolitzky F. Hogenauer C. Puschnig G. Hinterleitner T. Scheidl S. et al. (2012) Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study. Am J Gastroenterol 107: 372–378.
25. El-Serag H. (2008) Role of obesity in GORD-related disorders. Gut 57: 281–284.
26. El-Serag H. Lee P. Buchner A. Inadomi J. Gavin M. McCarthy D. (2001) Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 96: 979–983.
27. El-Serag H. Satia J. Rabeneck L. (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54: 11–17.
28. El-Serag H. Sonnenberg A. (1998) Opposing time trends of peptic ulcer and reflux disease. Gut 43: 327–333.
29. Fass R. Quan S. O'Connor G. Ervin A. Iber C. (2005) Predictors of heartburn during sleep in a large prospective cohort study. Chest 127: 1658–1666.
30. Fisher B. Pennathur A. Mutnick J. Little A. (1999) Obesity correlates with gastroesophageal reflux. Dig Dis Sci 44: 2290–2294.
31. Ford C. (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294: 1534–1540.
32. Fox M. Barr C. Nolan S. Lomer M. Anggiansah A. Wong T. (2007) The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol 5: 439–444.
33. Fraser-Moodie C. Norton B. Gornall C. Magnago S. Weale A. Holmes G. (1999) Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol 34: 337–340.
34. Freidin N. Mittal R. Traube M. McCallum R. (1989) Segmental high amplitude peristaltic contractions in the distal esophagus. Am J Gastroenterol 84: 619–623.
35. Freije J. Beatty T. Campbell B. Woodson B. Schultz C. Toohill R. (1996) Carcinoma of the larynx in patients with gastroesophageal reflux. Am J Otolaryngol 17: 386–390.
36. Giannini E. Zentilin P. Dulbecco P. Iiritano E. Bilardi C. Savarino E. et al. (2006) A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. Dig Dis Sci 51: 1904–1909.
37. Hamilton J. Boisen R. Yamamoto D. Wagner J. Reichelderfer M. (1988) Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci 33: 518–522.
38. Hogan W. Shaker R. (2001) Medical treatment of supraesophageal complications of gastroesophageal reflux disease. Am J Med 111(Suppl. 8A): 197S–201S.
39. Hopkins C. Yousaf U. Pedersen M. (2006) Acid reflux treatment for hoarseness. Cochrane Database Syst Rev 1: CD005054.
40. Jacobson B. Somers S. Fuchs C. Kelly C. Camargo C. Jr (2006) Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354: 2340–2348.
41. Jaspersen D. Kulig M. Labenz J. Leodolter A. Lind T. Meyer-Sabellek W. et al. (2003) Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 17: 1515–1520.
42. Johnston N. Dettmar P. Bishwokarma B. Lively M. Koufman J. (2007 a) Activity / stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 117: 1036–1039.
43. Johnston N. Wells C. Blumin J. Toohill R. Merati A. (2007 b) Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol 116: 934–938.
44. Jozkow P. Wasko-Czopnik D. Medras M. Paradowski L. (2006) Gastroesophageal reflux disease and physical activity. Sports Med 36: 385–391.
45. Kahrilas P. Gupta R. (1989) The effect of cigarette smoking on salivation and esophageal acid clearance. J Lab Clin Med 114: 431–438.
46. Kahrilas P. Shaheen N. Vaezi M. Hiltz S. Black E. Modlin I. et al. (2008) American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 135 (4): 1383–1391, 1391 e1381–e1385.
47. Kaltenbach T. Crockett S. Gerson L. (2006) Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 166: 965–971.
48. Kamel P. Hanson D. Kahrilas P. (1994) Omeprazole for the treatment of posterior laryngitis. Am J Med 96: 321–326.
49. Karkos P. Wilson J. (2006) Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 116: 144–148.
50. Katz P. Gerson L. Vela M. (2013) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108: 308–328; quiz 329.
51. Kaufman S. Kaye M. (1978) Induction of gastro-oesophageal reflux by alcohol. Gut 19: 336–338.
52. Khalil H. Bridger M. Hilton-Pierce M. Vincent J. (2003) The use of speech therapy in the treatment of globus pharyngeus patients. A randomised controlled trial. Rev Laryngol Otol Rhinol (Bord) 124: 187–190.
53. Khoury R. Camacho-Lobato L. Katz P. Mohiuddin M. Castell D. (1999) Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 94: 2069–2073.
54. Kjellin A. Ramel S. Rossner S. Thor K. (1996) Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol 31: 1047–1051.
55. Klein W. Parkman H. Dempsey D. Fisher R. (1993) Sphincterlike thoracoabdominal high pressure zone after esophagogastrectomy. Gastroenterology 105: 1362–1369.
56. Klopocka M. Sinkiewicz A. Budzynski J. Pulkowski G. Swiatkowski M. (2004) Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole. Med Sci Monit 10: PI115–PI118.
57. Koufman J. (1991) The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101(4 Pt 2 Suppl. 53): 1–78.
58. Koufman J. Aviv J. Casiano R. Shaw G. (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127: 32–35.
59. Koufman J. Sataloff R. Toohill R. (1996) Laryngopharyngeal reflux: consensus conference report. J Voice 10: 215–216.
60. Lam P. Ng M. Cheung T. Wong B. Tan V. Fong D. et al. (2010) Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol 8: 770–776.
61. Lee B. Kim G. (2012) Globus pharyngeus: a review of its etiology, diagnosis and treatment. World J Gastroenterol 18: 2462–2471.
62. Lien H. Wang C. Liang W. Sung F. Hsu J. Yeh H. et al. (2013) Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome. Laryngoscope, in press.
63. Lindstrom D. Wallace J. Loehrl T. Merati A. Toohill R. (2002) Nissen fundoplication surgery for extraesophageal manifestations of gastroesophageal reflux (EER). Laryngoscope 112: 1762–1765.
64. Ludemann J. Manoukian J. Shaw K. Bernard C. Davis M. al-Jubab A. (1998) Effects of simulated gastroesophageal reflux on the untraumatized rabbit larynx. J Otolaryngol 27: 127–131.
65. Mangano M. Colombo P. Bianchi P. Penagini R. (2002) Fat and esophageal sensitivity to acid. Dig Dis Sci 47: 657–660.
66. Masaany M. Marina M. Sharifa Ezat W. Sani A. (2011) Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. J Laryngol Otol 125: 502–508.
67. McGlashan J. Johnstone L. Sykes J. Strugala V. Dettmar P. (2009) The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 266: 243–251.
68. Millichap F. Lee M. Pring T. (2005) A lump in the throat: Should speech and language therapists treat globus pharyngeus? Disabil Rehabil 27: 124–130.
69. Milstein C. Charbel S. Hicks D. Abelson T. Richter J. Vaezi M. (2005) Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 115: 2256–2261.
70. Mittal R. Balaban D. (1997) The esophagogastric junction. N Engl J Med 336: 924–932.
71. Murphy D. Castell D. (1988) Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 83: 633–636.
72. Nasseri-Moghaddam S. Mofid A. Ghotbi M. Razjouyan H. Nouraie M. Ramard A. et al. (2008) Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor. Aliment Pharmacol Ther 28: 144–153.
73. Nebel O. Fornes M. Castell D. (1976) Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 21: 953–956.
74. Ness-Jensen E. Lindam A. Lagergren J. Hveem K. (2013) Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol 108: 376–382.
75. Nicholls S. (2013) Standards and classification: A perspective on the ‘obesity epidemic’. Soc Sci Med 87: 9–15.
76. Nilsson M. Johnsen R. Ye W. Hveem K. Lagergren J. (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53: 1730–1735.
77. Nocon M. Labenz J. Jaspersen D. Meyer-Sabellek W. Stolte M. Lind T. et al. (2007) Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol 22: 1728–1731.
78. Nocon M. Labenz J. Willich S. (2006) Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 23: 169–174.
79. Noordzij J. Khidr A. Evans B. Desper E. Mittal R. Reibel J. et al. (2001) Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 111: 2147–2151.
80. Oelschlager B. Barreca M. Chang L. Oleynikov D. Pellegrini C. (2003) Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 238: 458–464; discussion 464–456.
81. Orr W. Robinson M. Johnson L. (1981) Acid clearance during sleep in the pathogenesis of reflux esophagitis. Dig Dis Sci 26: 423–427.
82. Pacheco A. Cobeta I. Wagner C. (2013) Refractory chronic cough: new perspectives in diagnosis and treatment. Arch Bronconeumol 49: 151–157.
83. Pandolfino J. Bianchi L. Lee T. Hirano I. Kahrilas P. (2004) Esophagogastric junction morphology predicts susceptibility to exercise-induced reflux. Am J Gastroenterol 99: 1430–1436.
84. Pandolfino J. El-Serag H. Zhang Q. Shah N. Ghosh S. Kahrilas P. (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130: 639–649.
85. Papasavas P. Keenan R. Yeaney W. Caushaj P. Gagne D. Landreneau R. (2003) Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy. Surg Endosc 17: 1200–1205.
86. Parise P. Rosati R. Savarino E. Locatelli A. Ceolin M. Dua K. et al. (2011) Barrett's esophagus: surgical treatments. Ann N Y Acad Sci 1232: 175–195.
87. Park K. Choi S. Kwon S. Yoon S. Kim S. (2006) Diagnosis of laryngopharyngeal reflux among globus patients. Otolaryngol Head Neck Surg 134: 81–85.
88. Park W. Hicks D. Khandwala F. Richter J. Abelson T. Milstein C. et al. (2005) Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115: 1230–1238.
89. Parmelee-Peters K. Moeller J. (2004) Gastroesophageal reflux in athletes. Curr Sports Med Rep 3: 107–111.
90. Pearson J. Parikh S. Orlando R. Johnston N. Allen J. Tinling S. et al. (2011) Review article: reflux and its consequences–the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21–23 April 2010. Aliment Pharmacol Ther 33(Suppl. 1): 1–71.
91. Peghini P. Katz P. Castell D. (1998) Imipramine decreases oesophageal pain perception in human male volunteers. Gut 42: 807–813.
92. Pehl C. Pfeiffer A. Waizenhoefer A. Wendl B. Schepp W. (2001) Effect of caloric density of a meal on lower oesophageal sphincter motility and gastro-oesophageal reflux in healthy subjects. Aliment Pharmacol Ther 15: 233–239.
93. Pehl C. Pfeiffer A. Wendl B. Kaess H. (1998) Different effects of white and red wine on lower esophageal sphincter pressure and gastroesophageal reflux. Scand J Gastroenterol 33: 118–122.
94. Pehl C. Pfeiffer A. Wendl B. Nagy I. Kaess H. (1997) Effect of smoking on the results of esophageal pH measurement in clinical routine. J Clin Gastroenterol 25: 503–506.
95. Pehl C. Wendl B. Pfeiffer A. (2006) White wine and beer induce gastro-oesophageal reflux in patients with reflux disease. Aliment Pharmacol Ther 23: 1581–1586.
96. Pehl C. Wendl B. Pfeiffer A. Schmidt T. Kaess H. (1993) Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci 38: 93–96.
97. Penagini R. (2000) Fat and gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 12: 1343–1345.
98. Penagini R. Mangano M. Bianchi P. (1998) Effect of increasing the fat content but not the energy load of a meal on gastro-oesophageal reflux and lower oesophageal sphincter motor function. Gut 42: 330–333.
99. Qadeer M. Phillips C. Lopez A. Steward D. Noordzij J. Wo J. et al. (2006) Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 101: 2646–2654.
100. Qua C. Wong C. Gopala K. Goh K. (2007) Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy. Aliment Pharmacol Ther 25: 287–295.
101. Reichel O. Dressel H. Wiederanders K. Issing W. (2008) Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 139: 414–420.
102. Richter J. (2000) Extraesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol 95(8 Suppl.): S1–S3.
103. Richter J. (2004) Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum. Eur J Gastroenterol Hepatol 16: 837–845.
104. Richter J. (2013) Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol 11: 465–471.
105. Rossi M. Barreca M. de Bortoli N. Renzi C. Santi S. Gennai A. et al. (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 243: 58–63.
106. Ruigomez A. Garcia Rodriguez L. Wallander M. Johansson S. Graffner H. Dent J. (2004) Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 20: 751–760.
107. Sabate J. Jouet P. Merrouche M. Pouzoulet J. Maillard D. Harnois F. et al. (2008) Gastroesophageal reflux in patients with morbid obesity: a role of obstructive sleep apnea syndrome? Obes Surg 18: 1479–1484.
108. Sala E. Salminen P. Simberg S. Koskenvuo J. Ovaska J. (2008) Laryngopharyngeal reflux disease treated with laparoscopic fundoplication. Dig Dis Sci 53: 2397–2404.
109. Samuels T. Johnston N. (2010) Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngol 119: 203–208.
110. Savarino E. Bazzica M. Zentilin P. Pohl D. Parodi A. Cittadini G. et al. (2009) Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 179: 408–413.
111. Savarino E. de Bortoli N. Zentilin P. Martinucci I. Bruzzone L. Furnari M. et al. (2012) Alginate controls heartburn in patients with erosive and nonerosive reflux disease. World J Gastroenterol 18: 4371–4378.
112. Savarino E. Zentilin P. Marabotto E. Bonfanti D. Inferrera S. Assandri L. et al. (2011) Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis 43: 940–945.
113. Scarpignato C. Pelosini I. Di Mario F. (2006) Acid suppression therapy: where do we go from here? Dig Dis 24: 11–46.
114. Shaw G. Searl J. (1997) Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. South Med J 90: 1115–1122.
115. Sifrim D. Dupont L. Blondeau K. Zhang X. Tack J. Janssens J. (2005) Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 54: 449–454.
116. So J. Zeitels S. Rattner D. (1998) Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 124: 28–32.
117. Steward D. Wilson K. Kelly D. Patil M. Schwartzbauer H. Long J. et al. (2004) Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 131: 342–350.
118. Sun G. Muddana S. Slaughter J. Casey S. Hill E. Farrokhi F. et al. (2009) A new pH catheter for laryngopharyngeal reflux: Normal values. Laryngoscope 119: 1639–1643.
119. Suter M. Dorta G. Giusti V. Calmes J. (2004) Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg 14: 959–966.
120. Swoger J. Ponsky J. Hicks D. Richter J. Abelson T. Milstein C. et al. (2006) Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol 4: 433–441.
121. Talley N. Zinsmeister A. Schleck C. Melton L. III (1994) Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut 35: 619–624.
122. Terry P. Lagergren J. Ye W. Wolk A. Nyren O. (2001) Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 120: 387–391.
123. Tokashiki R. Yamaguchi H. Nakamura K. Suzuki M. (2002) Globus sensation caused by gastroesophageal reflux disease. Auris Nasus Larynx 29: 347–351.
124. Tutuian R. Mainie I. Agrawal A. Adams D. Castell D. (2006) Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 130: 386–391.
125. Vaezi M. (2010) Benefit of acid-suppressive therapy in chronic laryngitis: the devil is in the details. Clin Gastroenterol Hepatol 8: 741–742.
126. Vaezi M. Hicks D. Abelson T. Richter J. (2003) Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 1: 333–344.
127. Vaezi M. Qadeer M. Lopez R. Colabianchi N. (2006 a) Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med 119: 768–776.
128. Vaezi M. Richter J. Stasney C. Spiegel J. Iannuzzi R. Crawley J. et al. (2006 b) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116: 254–260.
129. Vakil N. Huff F. Bian A. Jones D. Stamler D. (2011) Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 106: 1427–1438.
130. Vakil N. van Zanten S. Kahrilas P. Dent J. Jones R. (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900–1920.
131. Viazis N. Keyoglou A. Kanellopoulos A. Karamanolis G. Vlachogiannakos J. Triantafyllou K. et al. (2011) Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol, in press.
132. Vitale G. Cheadle W. Patel B. Sadek S. Michel M. Cuschieri A. (1987) The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 258: 2077–2079.
133. Watanabe Y. Fujiwara Y. Shiba M. Watanabe T. Tominaga K. Oshitani N. et al. (2003) Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol 38: 807–811.
134. Wiener G. Tsukashima R. Kelly C. Wolf E. Schmeltzer M. Bankert C. et al. (2009) Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 23: 498–504.
135. Williams R. Szczesniak M. Maclean J. Brake H. Cole I. Cook I. (2004) Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol 99: 777–785.
136. Wo J. Koopman J. Harrell S. Parker K. Winstead W. Lentsch E. (2006) Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 101: 1972–1978; quiz 2169.
137. Wright L. Castell D. (1975) The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis 20: 703–707.
138. Xue S. Katz P. Banerjee P. Tutuian R. Castell D. (2001) Bedtime H 2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 15: 1351–1356.
139. Yamamichi N. Mochizuki S. Asada-Hirayama I. Mikami-Matsuda R. Shimamoto T. Konno-Shimizu M. et al. (2012) Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores. BMC Med 10: 45.
140. Zentilin P. Dulbecco P. Savarino E. Parodi A. Iiritano E. Bilardi C. et al. (2005) An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther 21: 29–34.
141. Zerbib F. Bruley des Varannes S. Roman S. Tutuian R. Galmiche J. Mion F. et al. (2011) Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR 5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 33: 911–921.
142. Zerbib F. Sifrim D. Tutuian R. Attwood S. Lundell L. (2013) Modern medical and surgical management of difficult-to-treat GORD. United Eur Gastroenterol J 1: 21–31.
143. Zerbib F. Stoll D. (2010) Management of laryngopharyngeal reflux: an unmet medical need. Neurogastroenterol Motil 22: 109–112.